Article
Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 10 Jun 2016
Vasen Hans, Ibrahim Isaura, Ponce Carmen Guillen, Slater Emily P, Matthäi Elvira, Carrato Alfredo, Earl Julie, Robbers Kristin, van Mil Anneke M, Potjer Thomas, Bonsing Bert A, de Vos Tot Nederveen Cappel Wouter H, Bergman Wilma, Wasser Martin, Morreau Hans, Klöppel Günter, Schicker Christoph, Steinkamp Martin, Figiel Jens, Esposito Irene, Mocci Evelina, Vazquez-Sequeiros Enrique, Sanjuanbenito Alfonso, Muñoz-Beltran Maria, Montans José, Langer Peter, Fendrich Volker, Bartsch Detlef K
Abstract excerpt
PURPOSE: Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis. Hereditary factors play a role in the development of PDAC in 3% to 5% of all patients. Surveillance of high-risk groups, may facilitate detection of PDAC at an early stage. The aim of this study was to assess whether surveillance aids detection of early-stage PDAC or precursor lesions (PRLs) and improves the prognosis. PATIENTS AND METHODS:...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.